CHICAGO — Low doses of atropine are the most effective in slowing myopia progression, according to a speaker here.
Multiple studies comparing different doses of atropine have shown a 0.01% dose has slowed myopia progression more so than doses of 0.05% or 0.1%, Donald Tan, MD, FRCS, FRCOphth, said at the American Academy of Ophthalmology meeting.
The ATOM1 trial, which was started in 1999, dosed 400 myopic children with 0.1% atropine for 2 years, with the third year being a washout year.
“After 2 years, we definitively showed a 77% (Read more...)
Uncategorized